Human cardiac mast cells in anaphylaxis

Chemical Immunology and Allergy

Volumn 95, Issue , 2010, Pages 98-109

  Genovese, Arturo ^a   Rossi, Francesca W ^a   Spadaro, Giuseppe ^a   Galdiero, Maria Rosaria ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; COMPLEMENT COMPONENT C5A RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; PEPTIDOLEUKOTRIENE; RENIN; TRYPTASE;

ANAPHYLAXIS; CELL ISOLATION; ENZYME RELEASE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MAST CELL; PRIORITY JOURNAL; REVIEW; SYNTHESIS;

ANAPHYLAXIS; ANIMALS; COMPLEMENT ACTIVATION; HEMODYNAMICS; HISTAMINE RELEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOTRIENE C4; MAST CELLS; MYOCARDIUM; PROSTAGLANDIN D2; RECEPTOR, ANAPHYLATOXIN C5A;

EID: 77954855095     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315945     Document Type: Review

References (63)

1. Bochner BS, Lichtenstein LM: Anaphylaxis. N Engl J Med 1991;324:1785.
2. Carswell F: Thirty deaths from asthma. Arch Dis Child 1985;60:25.
3. Delage C, Irey NS: Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Med 1972; 17:525.
4. Sampson HA, Mendelson L, Rosen JP: Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380.
5. Kemp SF, Lockey RF: Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341.
6. Bernreiter M: Electrocardiogram of patient in anaphylactic shock. JAMA 1959;170:1628.
7. Hanashiro PK, Weil MH: Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med 1967;119:129.
8. Booth BH, Patterson R: Electrocardiographic changes during human anaphylaxis. JAMA 1970;211:627.
9. Criep LH, Woehler TR: The heart in human anaphylaxis. Ann Allergy 1971;29:399
10. Sullivan TJ: Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. JAMA 1982;248:2161.
11. Ferrari S, Pietroiusti A, Galanti A, Compagnucci M, Fontana L: Paroxysmal atrial fibrillation after insect sting. J Allergy Clin Immunol 1996;98:759.
12. Levine HD: Acute myocardial infarction following wasp sting. Am Heart J 1976;91:365.
13. Bristow MR, Ginsburg R, Kantrowitz NE, Baim DS, Rosenbaum JT: Coronary spasm associated with urticaria: report of a case mimicking anaphylaxis. Clin Cardiol 1982;5:238.
14. Wong S, Greenberger PA, Patterson R: Nearly fatal idiopathic anaphylactic reaction resulting in cardiovascular collapse and myocardial infarction. Chest 1990;98:501.
15. Raper RF, Fisher MM: Profound reversible myocardial depression after anaphylaxis. Lancet 1988;1: 386.
16. Patella V, Marin Í, Lamparter B, Arbustini E, Adt M, Marone G: Human heart mast cells. Isolation, purification, ultrastructure and immunologic characterization. J Immunol 1995;154:2855.
17. Patella V, de Crescenzo G, Ciccarelli A, Marin Í, Adt M, Marone G: Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 1995;106:386.
18. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R: Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985;313:1138.
19. Kamat BR, Galli SJ, Barger AC, Lainey LL, Silverman KJ: Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. Hum Pathol 1987;18: 1036.
20. Kaartinen M, Penttil Á, Kovanen PT: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90:1669.
21. Kaartinen M, Penttil Á, Kovanen PT: Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase-and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb 1994; 14:966.
22. Laine P, Naukkarinen A, Heikkil Ĺ, Pentill Á, Kovanen PT: Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 2000;101:1665.
23. Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A: Immunological modulation of human cardiac mast cells. Neurochem Res 1999; 24:1195.
24. Patella V, Ciccarelli A, Lamparter-Schummert B, de Paulis A, Adt M, Marone G: Heterogeneous effects of protamine on human mast cells and basophils. Br J Anaesth 1997;78:724.
25. Patella V, Marin Í, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, Marone G: Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998;97:971.
26. Schechter NM, Irani AM, Sprows JL, Abernethy J, Wintroub B, Schwartz LB: Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol 1990;145:2652.
27. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990;265:22348.
28. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R: Mast cells: a unique source of renin. Proc Natl Acad Sci USA 2004;101:13607.
29. Mackins CJ, Kano S, Sevedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R: Cardiac mast cellderived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 2006;116:1063.
30. Advenier C, Sarria B, Naline E, Bybasset L, Lagente V: Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol 1990;100:168.
31. Hattori Y, Levi R: Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. J Pharmacol Exp Ther 1986;237: 719.
32. Vigorito C, Giordano A, Cirillo R, Genovese A, Rengo F, Marone G: Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. Int J Clin Lab Res 1997;27:178.
33. Sasayama S, Matsumori A, Kihara Y: New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res 1999;42:557.
34. Kaartinen M, Penttil Á, Kovanen PT: Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha;. Circulation 1996;94:2787.
35. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991;88:6382.
36. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992;149:599.
37. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O: Tumor necrosis factor-soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92:1479.
38. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL: Tumor necrosis factor and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704.
39. Marone G, Casolaro V, Paganelli R, Quinti I: IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989;93:246.
40. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599.
41. del Balzo U, Polley MJ, Levi R: Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects. J Pharmacol Exp Ther 1988;246:911.
42. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM: Physiologic manifestations of human anaphylaxis. J Clin Invest 1980;66:1072.
43. Schér H, Mathey D, Hugo F, Bhakdi S: Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 1986;137:1945.
44. Hachfeld del Balzo U, Levi R, Polley MJ: Cardiac dysfunction caused by purified human C3a anaphylatoxin. Proc Natl Acad Sci USA 1985;82:886.
45. del Balzo U, Polley MJ, Levi R: Cardiac anaphylaxis. Complement activation as an amplification system. Circ Res 1989;65:847.
46. de Paulis A, Ciccarelli A, Cirillo R, de Crescenzo G, Columbo M, Marone G: Modulation of human lung mast cell function by the c-kit receptor ligand. Int Arch Allergy Immunol 1992;99:326.
47. de Paulis A, Minopoli G, Arbustini E, de Crescenzo G, Dal Piaz F, Pucci P, Russo T, Marone G: Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol 1999;163:2799.
48. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G: Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation 1986;73: 1175.
49. Vigorito C, Giordano A, De Caprio L, Vitale DF, Maurea N, Silvestri P, Tuccillo B, Ferrara N, Marone G, Rengo F: Effects of histamine on coronary hemodynamics in man: role of H1 and H2 receptors. J Am Coll Cardiol 1987;10:1207.
50. Laroche D, Aimone-Gastin I, Dubois F, Huet H, Géard P, Vergnaud MC, Mouton-Faivre C, Guént JL, Laxenaire MC, Bricard H: Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998;209:183.
51. Capurro N, Levi R: The heart as a target organ in systemic allergic reactions: comparison of cardiac anaphylaxis in vivo and in vitro. Circ Res 1975;36: 520.
52. Marone G, Triggiani M, Cirillo R, Vigorito C, Genovese A, Spampinato N, Condorelli M: Chemical mediators and the human heart. Prog Biochem Pharmacol 1985;20:38.
53. Stellato C, de Crescenzo G, Patella V, Mastronardi P, Mazzarella B, Marone G: Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996;97:838.
54. Vigorito C, Russo P, Picotti GB, Chiariello M, Poto S, Marone G: Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol 1983;5:531.
55. Patterson LJ, Milne B: Latex anaphylaxis causing heart block: role of ranitidine. Can J Anaesth 1999; 46:776.
56. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG: Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 1999;55:1101.
57. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781.
58. Endou M, Poli E, Levi R: Histamine H3-receptor signaling in the heart: possible involvement of Gi/G0 proteins and N-type Ca2+ channels. J Pharmacol Exp Ther 1994;269:221.
59. Imamura M, Seyedi N, Lander HM, Levi R: Functional identification of histamine H3-receptors in the human heart. Circ Res 1995;77:206.
60. 2- adrenoceptors. Circ Res 1996;78:475.
61. Silver RB, Mackins CJ, Smith NCE, Koritchneva IL, Lefkowitz K, Lovenberg TW, Levi R: Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proc Natl Acad Sci USA 2001;98: 2855.
62. Silver RB, Poonwasi KS, Seyedi N, Wilson SJ, Lovenberg TW, Levi R: Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc Natl Acad Sci USA 2002;99:501.
63. Kamohara M, Takasaki J, Matsumoto M, Matsumoto S-I, Saito T, Soga T, Matsushime H, Furuichi K: Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 287:1088.